Lorazepam can be detected in urine for up to 6 days (144 hours) after a single dose. In a controlled study where volunteers took a single 2.5 mg dose, urine samples tested positive for the full 144-hour collection period, with concentrations ranging from 2 to 4 ng/mL at the tail end. Peak urine levels appeared around 24 hours after the dose, reaching 411 to 880 ng/mL before gradually declining.
What Drug Tests Actually Measure
Your body doesn’t excrete much lorazepam in its original form. Only about 0.3% of the dose leaves through urine as unchanged lorazepam. Instead, your liver converts the drug into a compound called lorazepam-glucuronide, and that metabolite is what accumulates in urine and triggers a positive result.
Standard urine drug screens for benzodiazepines use an initial immunoassay test with a cutoff of 100 ng/mL. This means your urine needs to contain at least that concentration for the test to flag as positive. Since lorazepam peaked at 411 to 880 ng/mL at the 24-hour mark in the study above and dropped to single digits by day 6, most people with a single low dose will fall below the cutoff well before that outer limit. However, the exact day you clear the threshold depends on your dose, how long you’ve been taking lorazepam, and your body’s processing speed.
Why Detection Times Vary Between People
Several factors push that 6-day window shorter or longer:
- Dose and duration of use. A single 1 mg dose clears faster than repeated daily dosing over weeks. Chronic use allows lorazepam-glucuronide to build up in your system, extending the detection window beyond what a single-dose study would suggest.
- Age. Older adults have reduced clearance rates for benzodiazepines. The liver and kidneys slow down with age, meaning the drug and its metabolites linger longer.
- Kidney function. Since the metabolite exits through the kidneys, impaired kidney function causes it to accumulate in the blood rather than being flushed into urine. In patients with chronic kidney disease, researchers found that lorazepam-glucuronide built up to high plasma concentrations over several days after just a single oral dose. This can both extend detection time and make urine levels less predictable.
- Alcohol use. Drinking alcohol around the same time as taking lorazepam reduces the drug’s clearance by roughly 18%. Alcohol interferes with the liver process that converts lorazepam into its metabolite, slowing the whole elimination timeline.
- Body composition and hydration. Higher body fat percentage, lower hydration, and slower metabolism all contribute to longer detection windows, though these effects are harder to quantify precisely.
How Lorazepam Compares to Other Benzodiazepines
Lorazepam is considered an intermediate-acting benzodiazepine. It clears faster than long-acting options like diazepam, which can be detectable in urine for weeks due to active metabolites that linger in the body. But it sticks around longer than ultra-short-acting benzodiazepines. The reason lorazepam’s metabolism is relatively straightforward is that it skips the complex liver oxidation step that other benzodiazepines require. It goes directly through a conjugation process, which is why liver disease and many common medications that affect liver enzymes don’t significantly change how fast lorazepam is processed. This makes its detection window more predictable than drugs like diazepam or chlordiazepoxide.
Practical Estimates by Usage Pattern
For a single therapeutic dose (0.5 to 2 mg), most healthy adults will test negative within 3 to 5 days. The 6-day mark represents the outer edge observed in controlled research with sensitive lab methods capable of detecting concentrations as low as 2 ng/mL, which is well below the 100 ng/mL screening cutoff used in standard workplace and clinical drug panels.
For regular daily use over weeks or months, expect a longer window. The metabolite accumulates with repeated dosing, and it takes additional days after the last dose for your kidneys to fully clear the backlog. In these cases, detection for 7 days or more is plausible, particularly in older adults or anyone with reduced kidney function.
If you’re facing a confirmatory test (which uses more precise lab methods rather than the initial screening), the specific cutoff and the lab’s sensitivity will determine the result. Confirmatory tests can identify lorazepam-glucuronide at lower concentrations than the initial screen, potentially extending the effective detection window by a day or two compared to what the standard immunoassay would catch.